Ameya Laboratories Ltd. - Research Center
532981 ANULABS Group (Z) BSE data
Results
Statement
More
Mar ' 12 |
Mar ' 11 |
Mar ' 10 |
Mar ' 09 |
Mar ' 08 |
Equity share capital
24.45 |
24.45 |
24.15 |
12.08 |
8.26 |
Share application money
Preference share capital
Reserves & surplus
140.97 |
137.53 |
136.88 |
133.83 |
43.37 |
Secured loans
91.74 |
60.89 |
70.13 |
39.51 |
39.55 |
Unsecured loans
18.63 |
0.63 |
11.04 |
1.14 |
1.14 |
Total
275.79 |
223.50 |
242.20 |
186.55 |
92.32 |
Gross block
117.80 |
117.10 |
51.65 |
32.88 |
26.87 |
Less : revaluation reserve
Less : accumulated depreciation
24.11 |
23.28 |
8.21 |
6.29 |
4.60 |
Net block
93.69 |
93.82 |
43.44 |
26.60 |
22.27 |
Capital work-in-progress
35.16 |
21.98 |
37.78 |
17.03 |
4.33 |
Investments
Current assets, loans & advances
213.99 |
183.90 |
191.37 |
171.52 |
96.61 |
Less : current liabilities & provisions
67.07 |
76.21 |
39.62 |
37.68 |
33.65 |
Total net current assets
146.93 |
107.69 |
151.76 |
133.84 |
62.96 |
Miscellaneous expenses not written
Total
275.79 |
223.50 |
242.20 |
186.55 |
92.32 |
Book value of unquoted investments
Market value of quoted investments
Contingent liabilities
2.21 |
42.44 |
1.07 |
0.97 |
1.67 |
Number of equity sharesoutstanding (Lacs)
2444.60 |
2444.60 |
2415.20 |
120.76 |
82.56 |